The medical economics of stroke. Discussion.
Satellite symposium on Haematological/Rheological and Neurological Aspects of Ischaemic Stroke. Anaheim (USA), 1997/02/08.
The economic consequences of the approximately 500 000 strokes that occur each year in the US are staggering.
The direct cost of providing care for stroke victims in 1993 has been estimated to be $US 17 billion. with an additional $US 13 billion in indirect costs attributable to lost earnings due to stroke-related mortality and morbidity.
Estimates of the cost of stroke over a patient's lifetime vary according to age at first stroke and type of stroke.
In 1990, these estimates ranged from SUS91 000 for ischaemic stroke, $US 124 000 for intracerebral haemorrhage, and SUS228 000 for subarachnoid haemorrhage.
Factors driving the economics of stroke include the epidemiology of stroke, treatment patterns and settings, and social and behavioural factors.
Evaluating the economic consequences of alternative interventions designed to prevent strokes or improve stroke outcomes involves a weighing of incremental costs and effectiveness.
Previous efforts have focused primarily on measuring costs, with a recent shift to trying to measure patient preferences for stroke outcomes.
Mots-clés Pascal : Accident cérébrovasculaire, Ischémie, Analyse coût, Economie santé, Article synthèse, Homme, Etats Unis, Amérique du Nord, Amérique, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie, Cérébrovasculaire pathologie, Appareil circulatoire pathologie, Vaisseau sanguin pathologie
Mots-clés Pascal anglais : Stroke, Ischemia, Cost analysis, Health economy, Review, Human, United States, North America, America, Nervous system diseases, Central nervous system disease, Cerebral disorder, Cerebrovascular disease, Cardiovascular disease, Vascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0035493
Code Inist : 002B17C. Création : 17/04/1998.